Stockreport

Seres Therapeutics to Initiate New SER-109 Clinical Study

Seres Therapeutics, Inc.  (MCRB) 
Last seres therapeutics, inc. earnings: 11/5 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.serestherapeutics.com
PDF – Positive SER-109 Type B FDA meeting – – Seres and FDA reach agreement on key design elements of a new SER-109 Phase 2 study in patients with mu [Read more]